Schuessler Tissue Salts Kali Sulph Skin Balance 7

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Schuessler Tissue Salts Kali Sulph Skin Balance 7
Generic name: KALI SULPHURICUM
Manufacturer: Martin & Pleasance Pty Ltd
Product type: HUMAN OTC DRUG
SPL set ID: 2b96b764-05d2-4122-9fc6-6ec86355b57c
SPL ID: 3b896371-e9ca-ce55-e063-6294a90aff6a
Version: 1
Effective date: 2025-08-04
Source export date: 2026-10-27
Source partition: 8
Source file: https://download.open.fda.gov/drug/label/drug-label-0008-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-27/2eee27992d1f29d82f827fd5be42f1314ed39ce4c497af5d81435ac6656a0957/drug-label-0008-of-0014.json.zip
Source manifest SHA-256: 6be3667a3beefe6c0ead4c723ea963050533a2bc725a8044d58b07d18b258c55
Import run: 20261027T193451Z
Imported at: 2026-10-27 20:23:10

Harmonized routes table
Harmonized routes
ORAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 9 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
brand name		Schuessler Tissue Salts Kali Sulph Skin Balance 7	openfda.brand_name
generic name		KALI SULPHURICUM	openfda.generic_name
manufacturer name		Martin & Pleasance Pty Ltd	openfda.manufacturer_name
ndc	package	84999-019-01	openfda.package_ndc
ndc	product	84999-019	openfda.product_ndc
ndc11	package	84999001901	derived:openfda.package_ndc
spl id		3b896371-e9ca-ce55-e063-6294a90aff6a	id
spl set id		2b96b764-05d2-4122-9fc6-6ec86355b57c	set_id
unii		1K573LC5TV	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings Stop use and ask a doctor if: Symptoms persist for more than 7 days or worsen Inflammation, fever, or infection is present or develops Fever gets worse or lasts more than 3 days If skin eruptions are severe, or painful seek the advice of a doctor. If pregnant or breastfeeding , ask a health professional before use. Keep out of reach of children.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.